International trial shows DNA test could help many breast cancer patients avoid chemotherapy
By
Alicia Curry
The kind of bagel you'd toss to the pigeons.
Summary
A new international trial presented at the American Society of Clinical Oncology conference suggests that millions of breast cancer patients could safely avoid chemotherapy. The study used tumor biology (DNA testing) to guide treatment decisions rather than traditional clinical features. Lead investigator Professor Rob Stein from UCL Cancer Institute says this marks progress toward more personalized treatment, potentially sparing many patients the physical and emotional burden of chemotherapy.
Key quotes
· 3 pulledThese results mark an important and significant step toward more personalised treatment.
The trial has successfully used tumour biology to guide decisions rather than relying solely on traditional clinical features.
For patients, this means many may be spared the physical and emotional burden
You might also wanna read
Breakthrough cancer test predicts whether chemotherapy will work
Tumor DNA Detected in Blood Years Before Cancer Diagnosis
Researchers have found that tumor DNA can be detected in the blood more than three years before a person is diagnosed with cancer, potential
Galleri Blood Test Shows Promise in Detecting 50 Types of Cancer in Large Clinical Trial
A large-scale clinical trial of the Galleri blood test, which detects cancer DNA fragments in blood, showed promising results with 25,000 pa
Engineered immunotherapy drug eliminates aggressive metastatic cancers in clinical trial
Researchers at Rockefeller University have developed an engineered CD40 agonist antibody that successfully eliminated aggressive metastatic
